Helen Boucher

Last updated
Helen Boucher
Helen Boucher USSCHELP.png
Boucher in 2023
Dean of the Tufts University School of Medicine
Assumed office
July 1, 2022

Helen Boucher (born 1964) is an American physician and infectiologist who is the dean of the Tufts University School of Medicine and the Chief Academic Officer of Tufts Medicine, the parent health system for Tufts Medical Center in Boston. [1] She is the first woman to serve as the dean of the Tufts University School of Medicine. [2]

Contents

Boucher previously served as Chief of the Division of Geographic Medicine and Infectious Diseases at Tufts Medical Center, a Professor of Medicine at Tufts University School of Medicine, and Director of the Stuart B. Levy Center for Integrated Management of Antimicrobial Resistance at Tufts.

Education

Boucher graduated with an undergraduate degree in English from the College of the Holy Cross in 1986 before earning a Doctor of Medicine (M.D.) in 1993 from the McGovern Medical School (formerly the University of Texas Medical School at Houston) in the Texas Medical Center. [3] From 1993 to 1997, she was a resident at Deaconess Hospital in Boston, Massachusetts, and was the hospital's chief resident in 1996–1997. Boucher then went on a clinical and research fellowship to Beth Israel Deaconess Medical Center, remaining there until 2000. [4]

Career

In October 2022, Boucher was named Dean of Tufts University School of Medicine. Boucher had served as the school’s dean ad interim since July 2021, when she was also named chief academic officer for Tufts Medicine, the parent health system for Tufts Medical Center in Boston.

Boucher has worked as a physician in the field of infectious diseases since the mid-1990s. [5] She is a professor at Tufts University [6] and the founding co-director of the Center for Integrated Management of Antimicrobial Resistance along with Ralph Isberg. [7] She has also served as the Director of the Infectious Diseases Fellowship Program at the Tufts Medical Center, [8] and until assuming the deanship at Tufts University School of Medicine was Chief of the Division of Geographic Medicine and Infectious Diseases. [3] [9] As a scholar, her research focuses on drug-resistant medical infections. [6] She has also commented on public medical issues in publications including the Washington Post . [10]

Boucher is also a member of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria, [11] [12] and is an associate editor of Infectious Diseases [13] and a member of the editorial board for Antimicrobial Agents and Chemotherapy . [14] Boucher is also treasurer of the Infectious Diseases Society of America. [15]

Personal life

Boucher is married to Norm Boucher, whom she met while they were both undergraduates at the College of the Holy Cross. They have two daughters. [16]

Related Research Articles

<i>Klebsiella pneumoniae</i> Species of bacterium

Klebsiella pneumoniae is a Gram-negative, non-motile, encapsulated, lactose-fermenting, facultative anaerobic, rod-shaped bacterium. It appears as a mucoid lactose fermenter on MacConkey agar.

<span class="mw-page-title-main">Tufts University School of Medicine</span> Private medical school in Boston, Massachusetts, US

The Tufts University School of Medicine is the medical school of Tufts University, a private research university in Massachusetts. It was established in 1893 and is located on the university's health sciences campus in downtown Boston. It has clinical affiliations with numerous doctors and researchers in the United States and around the world, as well as with its affiliated hospitals in both Massachusetts, and Maine.

<span class="mw-page-title-main">Steffanie Strathdee</span> Canadian epidemiologist (born 1966)

Steffanie A. Strathdee is a Harold Simon Distinguished Professor at the University of California San Diego School of Medicine and Co-Director at the Center for Innovative Phage Applications and Therapeutics. She is known for her work on HIV research and prevention programmes in Tijuana.

<span class="mw-page-title-main">Itzhak Brook</span> American academic

Itzhak Brook is an adjunct professor of pediatrics and medicine at Georgetown University School of Medicine, Washington DC. He specializes in infectious diseases. He is a past chairman of the Anti-infective Drug Advisory Committee of the Food and Drug Administration (FDA) and chaired the Committee when AZT was approved for the treatment of HIV/AIDS in 1987.

<span class="mw-page-title-main">Jay P. Sanford</span> American physician (1928–1996)

Jay Philip Sanford was a noted American military physician and infectious disease specialist. He held a chair in Tropical Medicine and was author of The Sanford Guide to Antimicrobial Therapy. From 1975 until 1990, he was dean, then president, of the Uniformed Services University of the Health Sciences in Bethesda, Maryland. He received numerous lifetime honors, awards, and accolades.

<span class="mw-page-title-main">Omadacycline</span> Chemical compound

Omadacycline, sold under the brand name Nuzyra, is a broad spectrum antibiotic medication belonging to the aminomethylcycline subclass of tetracycline antibiotics. In the United States, it was approved in October 2018, for the treatment of community-acquired bacterial pneumonia and acute skin and skin structure infections.

<span class="mw-page-title-main">Plazomicin</span> Antibiotic medication

Plazomicin, sold under the brand name Zemdri, is an aminoglycoside antibiotic used to treat complicated urinary tract infections. As of 2019 it is recommended only for those in whom alternatives are not an option. It is given by injection into a vein.

<span class="mw-page-title-main">Stuart B. Levy</span> American microbiologist, expert on antibiotic resistance

Stuart Blank Levy was a researcher and physician at Tufts University. He was among the first to advocate for greater awareness of antibiotic resistance and founded the Alliance for the Prudent Use of Antibiotics.

<span class="mw-page-title-main">Infectious diseases (medical specialty)</span> Medical specialty dealing with the diagnosis, control and treatment of infections

Infectious diseases (ID), also known as infectiology, is a medical specialty dealing with the diagnosis and treatment of infections. An infectious diseases specialist's practice consists of managing nosocomial (healthcare-acquired) infections or community-acquired infections. An ID specialist investigates and determines the cause of a disease. Once the cause is known, an ID specialist can then run various tests to determine the best drug to treat the disease. While infectious diseases have always been around, the infectious disease specialty did not exist until the late 1900s after scientists and physicians in the 19th century paved the way with research on the sources of infectious disease and the development of vaccines.

Kevin Outterson is a lawyer, a professor of law and the Austin B. Fletcher Professor Boston University School of Law (2023-present). He is also the executive director of Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator, a global non-profit partnership that supports companies developing new antibiotics, diagnostics, vaccines and other products to address drug-resistant bacterial infections.

Sherwood Leslie Gorbach is an Emeritus Professor at Tufts University School of Medicine. He was editor-in-chief of the journal Clinical Infectious Diseases from 2000 to 2016.

<span class="mw-page-title-main">Center for Innovative Phage Applications and Therapeutics</span> Phage therapy center in San Diego, CA, US

The Center for Innovative Phage Applications and Therapeutics (IPATH) is the first phage therapy center in North America, founded in the UC San Diego School of Medicine in June 2018, with seed funding from UC San Diego Chancellor Pradeep Khosla. The center was founded by Steffanie A. Strathdee and Robert "Chip" Schooley, both professors at UC San Diego School of Medicine. The center currently treats patients with life-threatening multi-drug resistant infections with phage therapy, on a case-by-case basis, through the Food and Drug Administration's (FDA's) compassionate use program. IPATH aims to initiate phase I/II phage therapy clinical trials, focusing on patients with cystic fibrosis and infections related to implantable hardware, such as pacemakers and prosthetic joints. The first planned clinical trial is set to look at otherwise healthy cystic fibrosis patients that are shedding Pseudomonas aeruginosa.

<span class="mw-page-title-main">Robert T. Schooley</span> American infectious disease physician

Robert "Chip" T. Schooley is an American infectious disease physician, who is the Vice Chair of Academic Affairs, Senior Director of International Initiatives, and Co-Director at the Center for Innovative Phage Applications and Therapeutics (IPATH), at the University of California San Diego School of Medicine. He is an expert in HIV and hepatitis C (HCV) infection and treatment, and in 2016, was the first physician to treat a patient in the United States with intravenous bacteriophage therapy for a systemic bacterial infection.

The Stuart B. Levy Center for Integrated Management of Antimicrobial Resistance is a center for research and education focusing on pathogens that exhibit antimicrobial resistance located at Tufts University and Tufts Medical Center.

Alison Helen Holmes is a British infectious diseases specialist, who is a professor at Imperial College London and the University of Liverpool. Holmes serves as Director of the National Institute for Health Research (NIHR) Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance and Consultant at Hammersmith Hospital. Holmes is on the Executive Committee of the International Society of Infectious Diseases, and she serves on a variety of World Health Organization (WHO) expert groups related to antimicrobial use, Antimicrobial Resistance (AMR), infection prevention and sepsis. Her research considers how to mitigate antimicrobial resistance.

Jasmine R. Marcelin is a Caribbean-American infectious disease physician and an Assistant Professor in the Department of Internal Medicine at the University of Nebraska Medical Center (UNMC). Marcelin is also the Associate Medical Director of the Antimicrobial Stewardship Program and as well as the Co-Director of Digital Innovation and Social Media Strategy at UNMC.

Alasdair Macintosh Geddes was a British medical doctor who was Professor of Infection at the University of Birmingham Medical School. In 1978, as the World Health Organization (WHO) was shortly to announce that the world's last case of smallpox had occurred a year earlier in Somalia, Geddes diagnosed a British woman with the disease in Birmingham, England. She was found to be the index case of the outbreak and became the world's last reported fatality due to the disease, five years after he had gained experience on the frontline of the WHO's smallpox eradication programme in Bangladesh in 1973.

Kerry L. LaPlante is an American pharmacist, academic and researcher. She is the Dean at the University of Rhode Island College of Pharmacy. She is a Professor of Pharmacy and former department Chair of the Department of Pharmacy Practice at the University of Rhode Island, an adjunct professor of medicine at Brown University, an Infectious Diseases Pharmacotherapy Specialist, and the Director of the Rhode Island Infectious Diseases Fellowship and Research Programs at the Veterans Affairs Medical Center in Providence, Rhode Island.

<span class="mw-page-title-main">Jameela Al Salman</span> Bahrani Professor and Physician

Jameela Al Salman is a Bahraini physician, infectious disease specialist, and associate professor at the Arabian Gulf University. She has won several awards and honors for her contributions to the field of medicine. Al Salman holds three American Board certifications: the American Board of Internal Medicine, the American Board of Geriatric Medicine, and the American Board of Infectious Diseases.

John Charles Sherris was an English-American medical doctor, pathologist, and bacteriologist. He was the president of the American Society for Microbiology (ASM) in 1983.

References

  1. "Helen Boucher Named Interim Dean at Tufts University School of Medicine". Tufts University School of Medicine. June 16, 2021. Retrieved 27 October 2024.
  2. "A Conversation with Helen Boucher, New Dean of Tufts School of Medicine and Chief Academic Officer of Tufts Medicine | Tufts Now". now.tufts.edu. 2022-10-21. Retrieved 2022-10-21.
  3. 1 2 "Holy Cross to Host Second Annual Women in Science Day | Newsroom | College of the Holy Cross". news.holycross.edu.
  4. "Faculty Profile: Helen Boucher, M.D." Tufts University. 2022. Retrieved 2024-10-26.
  5. EDT, David H. Freedman On 05/15/19 at 7:10 AM (May 15, 2019). "Doctors are running out of effective drugs because of poor financial incentives to develop them". Newsweek.{{cite web}}: CS1 maint: numeric names: authors list (link)
  6. 1 2 Hall, William (April 9, 2018). Superbugs: An Arms Race against Bacteria. Harvard University Press. ISBN   9780674985070 via Google Books.
  7. "Tufts Medical Center takes on life-threatening superbug infections". March 8, 2019.
  8. National Academy of Sciences, ed. (December 8, 2017). Combating Antimicrobial Resistance: A One Health Approach to a Global Threat: Proceedings of a Workshop. National Academies Press. ISBN   9780309466554 via Google Books.
  9. "'Superbug' infections are on the rise, a new CDC report says". Pittsburgh Post-Gazette.
  10. "First New Tuberculosis Drug Approved in 50 Years". The Scientist Magazine®.
  11. Turmelle, Luther (December 27, 2019). "Former New Haven drugmaker seeks bankruptcy protection". New Haven Register.
  12. Jacobs, Andrew (December 25, 2019). "Crisis Looms in Antibiotics as Drug Makers Go Bankrupt". The New York Times.
  13. "Medscape Infectious Diseases Editorial Board". www.medscape.com.
  14. Microbiology, American Society for (July 1, 2014). "Editorial Board". Antimicrobial Agents and Chemotherapy. 58 (7): A3. doi: 10.1128/AAC.masthead.58-7 . PMC   4068516 via aac.asm.org.
  15. "Board of Directors". www.idsociety.org.
  16. "Helen W. Boucher '86 Is First Woman Elected Chair of the Holy Cross Board of Trustees | Holy Cross Magazine". magazine.holycross.edu. Retrieved 2024-11-21.